Home
Technology
News
Contact
About

Select Page

Disclosures

Corporate and Scientific Integrity Policy

SEC Filings

This is the 2024 Form C-AR as required by the SEC.

Products are in development. This is potential future technology and not approved by the FDA and not commercially available. The innovations described above are all currently in development. Features and performances of future technologies may vary. Access to future technologies are contingent upon regulatory approval. Approval timelines are subject to the regulatory process of individual countries and regions and not guaranteed.

© 2022 Cytex Therapeutics, Inc now DBA CytexOrtho. All rights reserved